India Medical Devices Industry: The Shift from Consumption Hub to Global MedTech Base

insight-image


Introduction: Why the Indian Medical Devices Sector Is at an Inflection Point

For two decades India bought most of its medical technology from abroad. The government's own assessment put import dependence at more than 85% of the market in 2020, and the country's role was that of a large consumer rather than a producer. That position is now changing, as incentive schemes, multinational localization, and domestic innovation turn the Indian medical devices sector into a manufacturing and export base.

According to IMARC Group, the India Medical Devices Market size reached USD 19.11 Billion in 2025, rose to USD 20.23 Billion in 2026, and is projected to reach USD 31.85 Billion by 2034, growing at a CAGR of 5.83% (2026–2034). The inflection shows up on the export side as well: medical device exports grew from USD 2,532 Million in FY2020-21 to USD 4,014 Million in FY2024-25.

Demand fundamentals are durable. India has 101 Million people with diabetes, around 70,000 registered hospitals, over 1,200 cardiac catheterization laboratories as of 2024, and more than 600 ambulatory surgical centres growing at 18–20% annually, with medical tourism worth a USD 9 Billion opportunity.

This blog provides an India Medical Devices Market analysis covering segments, recent announcements, trends, regional hotspots, competitive strategies, policy and risks, and the long-range outlook for manufacturers, investors, and health systems.

Key Takeaways

  • The India Medical Devices Market was valued at USD 19.11 Billion in 2025 and is forecast to reach USD 31.85 Billion by 2034, at a CAGR of 5.83% (2026–2034).
  • Orthopedic devices lead by type with an 18.0% share, ahead of diagnostic imaging at 14.0% and cardiovascular devices at 12.0%, while in-vitro diagnostics and diabetes care together contribute 20.0% of revenue.
  • Hospitals and ambulatory surgical centres account for 70.0% of end-user demand, with clinics at 20.0%.
  • South India leads regionally with a 34.0% share and is also the fastest-growing region, followed by North India at 28.0% and West India at 22.0%.
  • The production-linked incentive scheme for medical devices has a Rs. 3,420 crore outlay, 27 approved applicants, and 24 commissioned greenfield projects producing 57 devices including MRI, CT, and linear accelerators.

Market Size, Share & Growth Outlook


According to IMARC Group, demand concentrates in high-volume surgical and diagnostic categories purchased mainly by institutional buyers. The India Medical Devices Market share across the leading segments breaks down as follows:

  • Type: Orthopedic devices lead with 18.0%, followed by diagnostic imaging at 14.0% and cardiovascular devices at 12.0%, a mix that reflects the country's procedure volumes in joint replacement, imaging, and interventional cardiology.
  • End User: Hospitals and ambulatory surgical centres hold 70.0%, with clinics at 20.0%, so tender cycles and hospital capital budgets set the pace of equipment sales.
  • Region: South India commands 34.0%, the largest and fastest-growing regional market, helped by its hospital density and medical tourism inflows.

Growth of roughly 5.83% a year understates the structural change underneath, because the composition of supply is shifting from imported finished devices to locally manufactured ones.

Recent News & Mega Announcements


Scheme disbursements, platform launches, and clinical scale-ups have all moved in the past 18 months:

  • In September 2026, SS Innovations reported 238 SSi Mantra surgical robot systems installed across 12 countries and 14,103 procedures completed, up 79% from the end of 2025, with about 1,500 physicians trained.
  • In March 2026, the Department of Pharmaceuticals told Parliament that the medical devices production-linked incentive scheme had reached cumulative eligible sales of Rs. 13,624.52 crore, including Rs. 6,425.48 crore of exports, with Rs. 157.15 crore in incentives disbursed to seven applicants.
  • In August 2025, Abbott introduced its FreeStyle Libre 2 Plus sensor with automatic glucose readings, extending continuous monitoring to a wider patient base.
  • In April 2025, Siemens Healthineers launched the MAGNETOM Flow magnetic resonance and SOMATOM Pro.Pulse computed tomography systems for the Indian imaging market.

The pattern is consistent: Indian facilities are increasingly where global platforms launch, build, and clinically validate, not just where they sell.

Industry Trends Shaping 2026


Three trends are transforming the medical devices market in India:

1. AI-Enabled Imaging, Diagnostics, and Connected Devices

Imaging and diagnostics are being rebuilt around algorithms and continuous data rather than single readings. Diagnostic imaging already holds 14.0% of revenue, and in-vitro diagnostics and diabetes care add a further 20.0%, the categories where artificial intelligence and wearable sensors land first. Abbott's FreeStyle Libre 2 Plus, launched in August 2025, delivers automatic glucose readings that feed digital care pathways, while the Ayushman Bharat Digital Mission crossed 90 crore health accounts by May 2026, creating the record layer that connected devices can write into.

2. Robotic and Minimally Invasive Surgical Systems

Surgical robotics has moved from pilot installations to routine use. SS Innovations' installed base reached 238 systems with 14,103 procedures by September 2026, including 258 pediatric robotic surgeries and 188 telesurgery procedures, with the longest telesurgery spanning more than 13,600 miles between Colombia and India. Domestically engineered platforms at lower price points make robotic surgery viable outside metro tertiary hospitals, and with hospitals and surgical centres accounting for 70.0% of demand, adoption follows hospital capital cycles.

3. Domestic Manufacturing and Medical Device Parks

Localization is the structural trend. The production-linked incentive scheme, with a Rs. 3,420 crore outlay running from FY2022-23 to FY2026-27 and 28 approved applicants, has seen 24 greenfield projects commissioned and production start for 57 products including linear accelerators, MRI machines, ultrasound systems, CT scanners, and X-ray equipment. Three medical device parks have been approved at Greater Noida, Ujjain, and Kanchipuram, with project costs above Rs. 871.11 crore, central assistance of Rs. 100 crore per park, and Rs. 210 crore already released. India Medical Devices Market trends now hinge on how much of this capacity converts into export-grade output.

India Medical Devices Market

Geographic Hotspots


South India leads with a 34.0% share and is the fastest-growing region, followed by North India at 28.0%, West India at 22.0%, and East India at 16.0%. The southern states combine hospital density, a large private tertiary care network, and most inbound medical travel, supporting demand for imaging, orthopedic, and cardiovascular devices.

Manufacturing and research footprints are spreading wider. The approved medical device parks place dedicated infrastructure in Uttar Pradesh, Madhya Pradesh, and Tamil Nadu, while Siemens Healthineers has committed about EUR 200 Million to an integrated campus in Bengaluru alongside Rs. 91.9 crore for local computed tomography and magnetic resonance manufacturing, and Philips has invested Rs. 750 crore across a Pune research centre and a Bengaluru innovation campus. Medtronic, Boston Scientific, GE HealthCare, and Stryker have also expanded engineering operations in Bengaluru and Hyderabad, making the south a design hub as well as the largest market.

Competitive Landscape & Key Players' Strategies


The top 10 companies account for approximately 40–50% of market revenue in 2025, leaving substantial room for domestic challengers in value segments. Strategies divide between multinationals localizing production and Indian firms building clinically validated platforms. Key players include:

  • Abbott: Launched the FreeStyle Libre 2 Plus sensor in August 2025, pushing continuous glucose monitoring deeper into the diabetes care segment.
  • Becton Dickinson and Company: Ranked among the market's leading players, it supplies consumables, injection, and infusion products that underpin hospital volumes.
  • GE HealthCare: Has expanded engineering and research operations in India, and is ranked among the market's leading players in imaging and monitoring.
  • Medtronic: Runs expanded engineering and research operations in Bengaluru and Hyderabad, and is ranked among the market's leading players in cardiovascular and surgical devices.
  • Philips: Has invested Rs. 750 crore in Indian research and innovation campuses and exports its locally built Zenition mobile C-arm series to more than 100 countries.
  • Siemens Healthineers: Manufactures computed tomography and magnetic resonance systems locally and exports its Cios Fit mobile C-arm to over 64 countries, and launched MAGNETOM Flow and SOMATOM Pro.Pulse in April 2025.
  • SS Innovations: Scales its India-built SSi Mantra surgical robot, with European CE marking anticipated by end-2026 and a United States regulatory review expected to conclude by the first quarter of 2027.

The competitive question for the next cycle is whether localized multinational plants or domestic platform builders capture the export opportunity first.

Policy & Regulatory Landscape, Challenges & Risks


Government policy is the main lever shaping medical device market access in India:

  • Production-Linked Incentive Scheme: Rs. 3,420 crore outlay with a five-year incentive period to FY2026-27, 28 approved applicants, and 24 greenfield projects commissioned.
  • Medical Device Parks: Three approved parks with Rs. 100 crore of central assistance each and Rs. 210 crore released in grant-in-aid, offering shared testing and infrastructure.
  • Ayushman Bharat Digital Mission: More than 90 crore health accounts created by May 2026, enabling consent-based exchange of health records, which supports digitally connected devices.
  • Investment Climate: Foreign direct investment in the sector totalled Rs. 20,658 crore from FY2018-19 to December 2025, including Rs. 5,253 crore in FY2024-25.

Key challenges and risks include:

  • Import dependence: Imports supplied more than 85% of the market as assessed in 2020, and industry estimates still put import reliance at 70–80%, concentrated in high-end equipment.
  • Pricing and affordability pressure: The National Pharmaceutical Pricing Authority extended knee implant ceilings to November 15, 2026, at Rs. 51,563 for primary and Rs. 83,547 for revision systems, rejecting industry requests for a 10% increase, which compresses margins in capped categories.
  • Scheme conversion risk: Incentives of only Rs. 157.15 crore have been disbursed to seven applicants against a Rs. 3,420 crore outlay, indicating that approved capacity is still working through production and qualification milestones.
  • Moderate headline growth: At a CAGR of 5.83% (2026–2034), value growth is steady rather than rapid, so returns depend on import substitution and export share rather than on domestic expansion alone.

Forecast 2026–2034


IMARC Group projects the market to grow from USD 20.23 Billion in 2026 to USD 31.85 Billion by 2034, a CAGR of 5.83% (2026–2034). Three streams carry that growth: hospital capital spending, chronic disease management devices, and exports from newly commissioned plants.

The future of the medical device industry in India depends on moving up the value chain. Exports have already climbed to USD 4,014 Million in FY2024-25 and locally made linear accelerators, MRI machines, and CT scanners are now in production, which is the step that separates a consumption hub from a manufacturing base. Investment opportunities concentrate in high-end imaging, surgical robotics, diagnostics, and components, where import substitution has the furthest to run.

Opportunities for Stakeholders


  • Device Manufacturers: Build in the approved device parks to access shared testing and infrastructure while incentive and export economics still favour new capacity.
  • Digital Health and MedTech Innovators: Design devices that write into the national health record system, where a nationwide account base is already in place.
  • Hospitals and Surgical Centre Chains: Adopt domestically built robotic and imaging platforms at lower capital cost to widen procedure access beyond metro centres.
  • Component and Contract Manufacturers: Supply the sensors, electronics, and precision parts that locally assembled equipment still imports.
  • Investors: Favour firms with export traction and multi-market clearances over those dependent on price-capped categories.

Conclusion: From Buyer to Builder in Global MedTech


India is no longer only a destination for medical technology; it is becoming a place where devices are engineered, manufactured, and exported. Production-linked incentives have commissioned plants for equipment the country once bought entirely from abroad, a domestically built surgical robot is operating across 12 countries, and a nationwide digital health backbone is in place, with the market forecast to grow at a CAGR of 5.83% (2026–2034).

For manufacturers, the priority is to convert approved capacity into export-grade, certified output. For investors, the value lies in high-end categories where import substitution is still unfinished. For policymakers, faster approvals and a pricing framework that rewards innovation will decide how far India climbs in the global MedTech order.

For more information on this market, write to us:

Please enter the Captcha text*

Our Clients

}
Rmd
Samudera
Amerisource
Skycell
Fedex
Alicorp
Maersk
DHL
Microsoft
United Parcel service

Contact Us

Have a question or need assistance?
Please complete the form with your inquiry or reach out to us at

Phone Number

+91-120-433-0800
+1-201-971-6302
+44-113-547-7077

Previous Post

Rapid Diagnostic Test Kit Plant Setup Cost in India: Manufacturing Process Flow, Machinery, DPR & Financial Model 2026
Rapid Diagnostic Test Kit Plant Setup Cost in India: Manufacturing Process Flow, Machinery, DPR & Financial Model 2026

Rapid diagnostic tests deliver results in minutes, without laboratory equipment, at a clinic, pharmacy, field camp, or at home. Lateral flow tests for malaria, dengue, typhoid, HIV, hepatitis, syphilis, pregnancy, fertility, drugs of abuse, and cardiac markers have become an essential part of India's healthcare system, especially in primary care and rural areas where laboratories are scarce.

Generic Injectables Plant Setup Cost in India: Manufacturing Process Flow, Machinery, DPR & Financial Model 2026
Generic Injectables Plant Setup Cost in India: Manufacturing Process Flow, Machinery, DPR & Financial Model 2026

Setting up a Generic Injectables Manufacturing Plant in India is a high-value, highly regulated venture, powered by the country's position as the pharmacy of the world, growing global demand for affordable injectables, and a wave of patent expiries opening new products to generic competition.

Pharmaceutical Manufacturing Plant Setup in India: Cost, Process Flow, Machinery, DPR & Financial Guide 2026
Pharmaceutical Manufacturing Plant Setup in India: Cost, Process Flow, Machinery, DPR & Financial Guide 2026

Setting up a Pharmaceutical Manufacturing Plant in India is a high-potential, strategically strong venture, powered by the country's position as the pharmacy of the world and one of the largest generic drug producers globally. India's deep formulation expertise, cost competitiveness, and vast domestic and export demand make a pharmaceutical manufacturing unit setup in India one of the most attractive opportunities in the healthcare sector.

Why is the Dental 3D Printing Market Attracting Renewed Investor Attention?
Why is the Dental 3D Printing Market Attracting Renewed Investor Attention?

The Dental 3D Printing Market is attracting renewed investor attention because the technology has moved from a promising adjunct to a default production method inside dental laboratories and clinics.

Vitamin Water Manufacturing Cost Analysis: Fortified Beverage Cost Intelligence
Vitamin Water Manufacturing Cost Analysis: Fortified Beverage Cost Intelligence

Vitamin water is a functional, non-carbonated beverage that is created by the fortification of purified water with a combination of vitamins, minerals, and sometimes electrolytes, along with natural or artificial flavors and sweeteners. It is placed in a category between bottled water and carbonated soft drinks, providing hydration with a functional twist.

Vitamin B12 Manufacturing Cost Analysis: Small Molecule, Strategic Economics
Vitamin B12 Manufacturing Cost Analysis: Small Molecule, Strategic Economics

Vitamin B12, or cobalamin, is a water-soluble vitamin that contains the metal cobalt and is a micronutrient required by the human body. It acts as a coenzyme in the synthesis of DNA, the production of red blood cells, and the functioning of the nervous system.

How Big Will Japan’s Nutritional Supplements Market
How Big Will Japan’s Nutritional Supplements Market

Japan's dietary supplements industry has become one of the most advanced and innovation-led industries in the world. It is at the nexus of science, culture, and consumer health awareness.

Syringe Manufacturing Cost Analysis: Clean Manufacturing, Clear Costs
Syringe Manufacturing Cost Analysis: Clean Manufacturing, Clear Costs

A syringe is a medical instrument that is used to inject fluids into the body or to withdraw fluids from the body. A syringe usually has a cylindrical body, a plunger that moves inside the body to generate pressure or suction, and a nozzle to which a needle can be attached.

Australia Cosmetic Surgery Industry Analysis: Trends Transforming the Beauty and Wellness Sector
Australia Cosmetic Surgery Industry Analysis: Trends Transforming the Beauty and Wellness Sector

Cosmetic surgery in Australia today has evolved into a significant element of the greater beauty and wellness economy. Changing cultural attitudes, advances in medical aesthetics, and the rise of social media over the last ten years have reconstituted the ways in which cosmetic surgery is perceived and undertaken by Australians.

Factors Driving Growth in the Contact Lenses Market
Factors Driving Growth in the Contact Lenses Market

The contact lenses market represents a dynamic segment of the global vision care industry, characterized by continuous innovation and expanding demographic demand.

How Big Will the Brazil Diagnostic Imaging Equipment Market Be by 2034?
How Big Will the Brazil Diagnostic Imaging Equipment Market Be by 2034?

Brazil's diagnostic imaging equipment market stands at a pivotal moment as Latin America's largest and most dynamic healthcare arena. With substantial investments in hospital modernization, regulatory reforms, and artificial intelligence adoption, the market is transforming rapidly. As providers transition from analog to AI-ready platforms, Brazil emerges as a critical destination for medical device manufacturers seeking growth through the next decade.

Top Factors Driving Growth in the India Telemedicine Industry
Top Factors Driving Growth in the India Telemedicine Industry

The Indian healthcare space has indeed been changing. Telemedicine has emerged as one of the most important drivers of this change. Driving this transformation is the increased adoption of digital tools, growing patient awareness, and the pressing need to make healthcare more accessible across diverse geographies.

Australia Medical Aesthetics Industry: Analysis of Key Trends Shaping the Future of the Industry
Australia Medical Aesthetics Industry: Analysis of Key Trends Shaping the Future of the Industry

The Australia medical aesthetics industry size reached USD 396.4 Million in 2025. Looking forward, the market is expected to reach USD 784.8 Million by 2034, exhibiting a growth rate (CAGR) of 7.89% during 2026-2034. Over the last ten years, the medical aesthetic industry in Australia has transformed from a niche beauty service into a mainstream part of healthcare and wellness.

Rapid Diagnostic Test Kit Manufacturing Cost Analysis: Fast Results, Smart Economics
Rapid Diagnostic Test Kit Manufacturing Cost Analysis: Fast Results, Smart Economics

A rapid diagnostic test (RDT) kit is a medical device designed to quickly detect specific biomarkers, antigens, antibodies, or nucleic acids linked to diseases—typically within minutes and without the need for sophisticated laboratory equipment. These kits often use lateral flow assays, immunochromatographic strips, or rapid molecular testing methods to deliver fast and reliable results.

Philippines Pharmaceutical Industry: Generic Drugs Surge, Major Sectors, Leading Companies
Philippines Pharmaceutical Industry: Generic Drugs Surge, Major Sectors, Leading Companies

The Philippines pharmaceutical industry stands as one of Southeast Asia's most dynamic and rapidly expanding healthcare markets in the ASEAN region. With a market valuation reaching USD 3.36 Billion in 2025, the sector demonstrates resilience and tremendous growth potential.

Pharmaceutical Manufacturing Cost Analysis: Prescription for Profitability
Pharmaceutical Manufacturing Cost Analysis: Prescription for Profitability

Pharmaceuticals are medical products, substances, or formulations involved in the development, manufacture, and regulation for the prevention, diagnosis, treatment, and management of diseases in humans as well as animals.

Australia Aged Care Market: Elderly Care Reform, Digital Health Integration, Trends & Growth Drivers
Australia Aged Care Market: Elderly Care Reform, Digital Health Integration, Trends & Growth Drivers

The Australia aged care industry stands at a pivotal juncture as the nation grapples with demographic shifts that are reshaping the landscape of elderly care services. With an aging population that continues to expand, Australia faces both unprecedented challenges and remarkable opportunities in delivering quality care to its senior citizens.

How Government Policies Are Driving the India Vaccines Industry
How Government Policies Are Driving the India Vaccines Industry

The Indian vaccines industry holds an unparalleled position globally, often celebrated as the pharmacy of the world due and its massive production scale and capabilities. It reached INR 113.7 Billion in 2024 according to IMARC Group and it is projected to grow at a CAGR of 8.8% from 2025-2033.

Medical Imaging Market Trends: Advancing AI-Driven Diagnostics and Future-Ready Healthcare Systems
Medical Imaging Market Trends: Advancing AI-Driven Diagnostics and Future-Ready Healthcare Systems

The medical imaging market has reached a transformational phase, driven both by rapid technological advancements and growing demands for precision-driven diagnostics. As health systems worldwide come under increasing pressure to improve patient outcomes while minimizing procedural risks and optimizing clinical workflows, medical imaging has become one of the most important cornerstones of modern medicine.

How Big Will the India Medical Devices Industry Be by 2033
How Big Will the India Medical Devices Industry Be by 2033

India’s medical devices industry is on a sustained growth trajectory driven by expanding hospital infrastructure, rising chronic disease burden, stronger local manufacturing supported by government incentives, and a rapidly growing shift toward portable and home care devices.

Pectin Manufacturing Cost Analysis: Gelling the Margins
Pectin Manufacturing Cost Analysis: Gelling the Margins

Pectin represents a naturally occurring polysaccharide mainly extracted from cell walls of fruits (mainly from citrus peel and apple pomace). It is a soluble dietary fiber and a hydrocolloid with gelling, thickening, and stabilizing properties. It is mostly composed of galacturonic acid units.

Paracetamol Manufacturing Cost Analysis: Affordable Relief, Engineered Costs
Paracetamol Manufacturing Cost Analysis: Affordable Relief, Engineered Costs

Paracetamol, also referred to as acetaminophen, is an analgesic and antipyretic compound that is commonly used worldwide for the treatment of mild to moderate pain and the management of fever. The mechanism of action occurs mainly in the central nervous system, where it inhibits the mechanisms that regulate pain and body temperature, but lacks anti-inflammatory properties.

Australia Wellness Tourism Industry: Nature, Trends, Key Growth Drivers
Australia Wellness Tourism Industry: Nature, Trends, Key Growth Drivers

The Australia wellness tourism industry has emerged as a critical segment of the country’s broader travel and hospitality sector. It reflects a growing global emphasis on health, self-care, and holistic well-being, capturing the attention of travelers seeking experiences that combine relaxation, rejuvenation, and personal growth.

How big will the Brazil cardiovascular devices market be in 2034?
How big will the Brazil cardiovascular devices market be in 2034?

The Brazil cardiovascular devices market represents a crucial segment in the country’s healthcare ecosystem, addressing one of the leading causes of morbidity and mortality: cardiovascular diseases. Conditions such as heart attacks, stroke, arrhythmias, and heart failure require ongoing medical intervention and advanced heart disease treatment solutions. With the rising prevalence of cardiovascular disorders, demand for comprehensive cardiac care equipment and innovative treatment modalities is increasing.

Top Factors Driving Growth in the India Ayurvedic Products Industry
Top Factors Driving Growth in the India Ayurvedic Products Industry

India's Ayurvedic products market is experiencing remarkable transformation as consumers increasingly prioritize holistic wellness and natural remedies over conventional alternatives. The convergence of traditional healing wisdom with modern consumer preferences has created a dynamic landscape where herbal medicines, chemical-free personal care products, and immunity-boosting supplements are becoming household staples.

Nicotine Pouches Manufacturing Cost Analysis: Economics in Every Pouch
Nicotine Pouches Manufacturing Cost Analysis: Economics in Every Pouch

Nicotine pouches are small, smokeless oral delivery products of nicotine, free from tobacco, designed to allow for controlled release of the active principle without burning, vaporizing, or use of traditional tobacco leaves. It consists of a small pouch that contains a matrix made basically from plant fibers, flavorings, pH adjusters, and stabilizers impregnated with nicotine, encased in a permeable material permitting the gradual absorption of the product via the oral mucosa.

Japan Pharmaceutical Industry Outlook: Key Growth Factors and Regulatory Support
Japan Pharmaceutical Industry Outlook: Key Growth Factors and Regulatory Support

The pharmaceutical industry in Japan is among the most advanced globally, recognized for combining innovation, high-quality standards, and patient-centered care. Its extensive value chain includes drug discovery, clinical trials, manufacturing, distribution, marketing, and post-market surveillance. Serving both domestic and international markets, Japanese pharmaceutical companies are respected for regulatory compliance, safety, and reliability, establishing them as trusted global collaborators in drug development.

Key Growth Drivers of the Japan Dry Eye Syndrome Industry
Key Growth Drivers of the Japan Dry Eye Syndrome Industry

The pharmaceutical industry in Japan is among the most advanced globally, recognized for combining innovation, high-quality standards, and patient-centered care. Its extensive value chain includes drug discovery, clinical trials, manufacturing, distribution, marketing, and post-market surveillance. Serving both domestic and international markets, Japanese pharmaceutical companies are respected for regulatory compliance, safety, and reliability, establishing them as trusted global collaborators in drug development.

AI-Powered Transformation in the Global Healthcare IT Market: Trends and Challenges
AI-Powered Transformation in the Global Healthcare IT Market: Trends and Challenges

The global healthcare IT industry is on a remarkable upswing, fueled by the surge in preventive care, digital health platforms, and smarter patient management systems. According to IMARC Group, the market hit USD 363.15 Billion in 2024, a clear sign of worldwide adoption. An aging population, the growing comfort with remote care, and the push toward personalized medicine are all speeding this momentum.

AI-Powered Transformation in the Global Endoscopy Devices Market
AI-Powered Transformation in the Global Endoscopy Devices Market

The global endoscopy devices market is on a sharp growth path, fueled by the shift toward minimally invasive procedures, the need for early diagnosis, and cutting-edge imaging technologies. IMARC Group reported the market hit USD 50.01 Billion in 2024, underscoring its worldwide acceptance.

How Big Will be the B2B Payments Market by 2033?
How Big Will be the B2B Payments Market by 2033?

The global business-to-business (B2B) payments landscape is experiencing a fundamental transformation that is reshaping how enterprises conduct financial transactions across borders and industries. The market, valued at approximately 1,189.6 Billion in 2024, is projecting remarkable growth with expectations to reach USD 2,189.0 Billion by 2033, exhibiting a CAGR of 7% from 2025-2033. This exponential expansion is signaling a paradigm shift in commercial finance, driven by technological innovation, changing business expectations, and the urgent need for more efficient payment infrastructures.

How Big Will the Smart Medical Devices Industry be by 2033?
How Big Will the Smart Medical Devices Industry be by 2033?

The smart medical devices market is entering a decade defined by connected care, real-time diagnostics, and patient empowerment. Valued at USD 45.9 Billion in 2024, the market is projected to reach USD 82 Billion by 2033, expanding at a compound annual growth rate (CAGR) of 6.33% between 2025 and 2033 by IMARC Group. This steady rise reflects growing confidence in data-driven healthcare systems, integration of IoT in medical environments, and the increasing role of artificial intelligence in clinical decision-making.

Active Pharmaceutical Ingredients Cost Model: Breaking Down the Economics of Drug Manufacturing
Active Pharmaceutical Ingredients Cost Model: Breaking Down the Economics of Drug Manufacturing

Active Pharmaceutical Ingredients (APIs) are the bioactive molecules of any drug used in pharmaceuticals, which cause the desired therapeutic action in the body of a human being. APIs are the central core of all drugs, chemical or biological and are responsible for the efficacy, strength, and safety of the drug. APIs are synthesized by various complex chemical synthesis, fermentation, biotechnological, or extraction processes based on the type of drug.

Bio Medical Incinerator Cost Model: From Hazardous Waste to Safe Disposal
Bio Medical Incinerator Cost Model: From Hazardous Waste to Safe Disposal

A bio medical incinerator is a high-temperature combustion system specialized for biomedical waste disposal by hospitals, clinics, laboratories, and research institutions. Biomedical waste usually consists of infectious waste, pathological waste, sharps, pharmaceuticals, and contaminated disposables that are very hazardous to human health and the environment if not treated.

The Future of Obesity Treatment: From Personalized Medicine to AI Solutions
The Future of Obesity Treatment: From Personalized Medicine to AI Solutions

Obesity, once viewed primarily as a lifestyle choice, is now widely recognized as a complex and chronic disease characterized by excessive body fat accumulation. Its global prevalence is escalating at an alarming rate posing a significant and growing challenge to public health systems worldwide.

How AI is Impacting Gonorrhea Risk Assessment, Prevention & Early Diagnosis?
How AI is Impacting Gonorrhea Risk Assessment, Prevention & Early Diagnosis?

Gonorrhea, a sexually transmitted infection caused by the bacterium Neisseria gonorrhoeae, is a major public health issue globally. Reports show that over one million new cases of curable STIs are contracted every day by individuals aged 15 to 49 years, with the majority being asymptomatic.

Allergic Conjunctivitis Market Size to Reach USD 2.9 Billion by 2035, Impelled by Advancements in Novel Ocular Drug Delivery Systems
Allergic Conjunctivitis Market Size to Reach USD 2.9 Billion by 2035, Impelled by Advancements in Novel Ocular Drug Delivery Systems

The 7 major allergic conjunctivitis markets reached a value of USD 2.1 Billion in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 2.9 Billion by 2035, exhibiting a growth rate (CAGR) of 3.00% during 2025-2035.

How Telemedicine and AI are Revolutionizing Chronic Disease Management?
How Telemedicine and AI are Revolutionizing Chronic Disease Management?

The healthcare sector is changing rapidly because of the growing demand for better ways to manage chronic diseases. As we move toward 2025 and beyond, digital tools are playing an important role in dealing with conditions like diabetes, heart disease, cancer, and respiratory problems.

Multivitamin Gummies Production Plant Setup: A Comprehensive Cost Model
Multivitamin Gummies Production Plant Setup: A Comprehensive Cost Model

The global multivitamin gummies market consists of chewable dietary supplements that are charged with key vitamins and minerals aimed at maintaining general health and wellness. The gummies present a handy, enjoyable, and easy-to-swallow option to classic pills or tablets, hence are predominantly preferred by children and adults who do not like taking pills.

How AI is Transforming India's Pharmaceutical Industry
How AI is Transforming India's Pharmaceutical Industry

India's pharmaceutical sector is evolving rapidly, supported by the integration of artificial intelligence (AI) across the value chain. As of 2023, India ranked as the third-largest pharmaceutical producer by volume, accounting for 20% of global generic drug exports.

AI in Lung Cancer Treatment: Transforming Risk Detection, Prevention & Early Diagnosis
AI in Lung Cancer Treatment: Transforming Risk Detection, Prevention & Early Diagnosis

As Lung Cancer Awareness continues to build global momentum in 2025, Artificial Intelligence (AI) is proving to be a transformative force—not only in clinical diagnostics but also in public education and preventive health efforts. Given that lung cancer remains one of the world’s deadliest cancers, accounting for over 1.8 million deaths each year and a five-year survival rate of just 28.4%, the integration of AI marks a critical turning point.

Hepatitis Testing Day 2025: Advancing Early Detection and Global Health Outcomes
Hepatitis Testing Day 2025: Advancing Early Detection and Global Health Outcomes

Observed on May 19, Hepatitis Testing Day 2025 emphasizes the need to "Test. Treat. Eliminate," highlighting the gap in diagnosing hepatitis B and C, which cause over 1.3 million deaths annually. Hepatitis remains a major global health threat, on par with HIV, tuberculosis, and malaria. The growing viral hepatitis market <Viral Hepatitis Market Size | Share, Trends - 2034 > reflects rising demand for better diagnostics, treatments, and integrated care. The WHO warns that without faster testing and treatment, the goal of eliminating hepatitis by 2030 may not be achieved, with disparities in diagnostics, particularly in low- and middle-income countries, hindering progress.

World Ovarian Cancer Day - Key Facts and Awareness Points
World Ovarian Cancer Day - Key Facts and Awareness Points

Observed on May 8, World Ovarian Cancer Day 2025 carries the theme “No Woman Left Behind,” reinforcing the urgent need to close the gaps in access, diagnosis, treatment, and care across all regions and socioeconomic groups. Ovarian cancer remains one of the deadliest gynecological cancers, often detected too late due to vague symptoms and limited screening tools. The World Ovarian Cancer Coalition projects a 55% rise in annual cases and nearly 70% more deaths by 2050, with the heaviest burden falling on low- and middle-income countries. Equitable access to early diagnostics, genetic testing, and targeted therapies is critical.

World Asthma Day 2025: Strengthening Global Awareness and Response
World Asthma Day 2025: Strengthening Global Awareness and Response

In clinics around the world, a concerning pattern is becoming increasingly evident: a growing number of patients are experiencing wheezing, breathlessness, and persistent coughing. This surge reflects a broader global trend. According to the World Health Organization (WHO), more than 260 million people are currently living with asthma, making it one of the most widespread and persistent chronic respiratory conditions globally.

World Malaria Day 2025: A Turning Point in Global Immunization
World Malaria Day 2025: A Turning Point in Global Immunization

Observed on April 25, World Malaria Day 2025 carries the theme “Accelerating Equity in Malaria Prevention and Cure,” underscoring the urgent need to reach communities still lacking access to life-saving vaccines and diagnostics. While global malaria death rates have seen modest declines, the disease continues to claim the life of one child every minute, highlighting the critical need for swift, equity-driven action

Profitability and Cost Analysis of Sulfamethoxazole Manufacturing Plant: A Cost Model Approach
Profitability and Cost Analysis of Sulfamethoxazole Manufacturing Plant: A Cost Model Approach

Sulfamethoxazole is a common synthetic antibacterial that is a member of the sulfonamide class of antibiotics. This substance plays a very significant role in modern medicine due to the amazing capabilities offered by the substance for curing infections and bacterial diseases. Trimethoprim and sulfamethoxazole are frequently used together to create the well-known antibiotic co-trimoxazole, which is well-known for its potency against a variety of bacterial infections. It works by preventing the manufacture of folic acid, which is necessary for the growth of bacteria. Sulfamethoxazole is an essential part of modern antibiotic therapy since it has been used to treat lung infections, urinary tract infections, and other common bacterial illnesses.

Capital and Operational Cost Model of Healthcare Consumables Manufacturing Plant: A Detailed Cost Model
Capital and Operational Cost Model of Healthcare Consumables Manufacturing Plant: A Detailed Cost Model

Healthcare consumables are necessary medical supplies used for patient treatment, diagnostics, and cleanliness in clinics, hospitals, and home care settings. These consist of supplies such as surgical masks, bandages, gloves, syringes, catheters, and disinfectants. Usually, they are disposable or single use to preserve sterility and stop infections. Healthcare consumables are an essential component of the global healthcare ecosystem and are in high demand due to expanding healthcare needs, an increase in operations, infection control measures, and technological improvements.

Optimizing Catheter Production: A Comprehensive Cost Analysis
Optimizing Catheter Production: A Comprehensive Cost Analysis

Catheters are flexible, tubular medical devices designed to access various body cavities, organs, or blood vessels for diagnostic or therapeutic purposes. They can be broadly classified into types based on their application, including urinary catheters, cardiac catheters, and intravenous (IV) catheters. Catheters are commonly used in diverse healthcare settings for managing chronic conditions, enabling fluid drainage, delivering medications, or facilitating minimally invasive surgeries.

Bioinformatics: Unlocking the Secrets of the Genome
Bioinformatics: Unlocking the Secrets of the Genome

Bioinformatics involves applying computational techniques and tools to study and understand biological systems at the molecular level. It is a field of study that combines mathematics, biology, computer science, and statistics to research genomic data and biological networks. The goal is to interpret information from large biological data sets, such as DNA sequences, protein structures, gene expressions, and other high-throughput experimental data. This field provides various products and services, such as knowledge management tools, bioinformatics platforms, and services.

Australia's Roadmap to Excellence: Non-Animal Models at the Forefront of Medical Progress
Australia's Roadmap to Excellence: Non-Animal Models at the Forefront of Medical Progress

A non-animal model refers to an experimental system or method used in scientific research or testing that does not involve the use of animals. These models are developed to simulate biological processes, test hypotheses, or study diseases without the need for live animals. The aim is often to reduce the reliance on animal testing, which has ethical implications and raises concerns about animal welfare.

Revolutionizing Medicine: FDA Explores Innovations to Propel Cell and Gene Therapy Advancements
Revolutionizing Medicine: FDA Explores Innovations to Propel Cell and Gene Therapy Advancements

Cell therapy involves the transplantation and manipulation of living cells to replace and repair damaged tissue. Its primary branches include stem cell therapy and non-stem cell therapy. Stem cell therapy utilizes stem cells to repair, replace, or rejuvenate damaged or diseased cells and tissues as they possess the ability to differentiate into various specialized cell types, making them valuable for regenerative medicine. Non-stem cell-based therapies typically involve somatic cells isolated from the human body. These cells are propagated, expanded, selected, and then administered to patients for curative, preventive, or diagnostic purposes. On the other hand, gene therapy seeks to treat diseases by introducing, replacing, or inactivating genes within cells.